-
Molbio Diagnosti
1,393.10 925.80(%) -
Pine Labs
206.10 283.70(%) -
Larsen & Toubro
3,880.55 3,288.65(%) -
HDFC Bank
708.90 1,020.35(%) -
Power Grid Corpn
268.30 250.05(%) -
ESDS Software
1,716.35 1,716.35(%) -
Trent
2,815.00 3,497.35(%) -
Raymond
1,024.00 1,024.00(%) -
Metro Brands
924.20 883.40(%) -
Reliance Industries
1,253.20 1,250.55(%) -
Billionbrains
200.90 227.00(%) -
Ather Energy
1,615.00 530.65(%) -
One 97
1,829.50 1,829.50(%) -
Hind.Aeronautics
4,861.65 3,479.20(%) -
UPL
567.25 558.00(%) -
HDFC Life Insur.
531.15 796.60(%) -
Bajaj Finance
1,015.40 788.40(%) -
Lodha Developers
1,076.00 650.85(%) -
Dhoot Transmission
1,727.35 1,727.35(%) -
Britannia Inds.
4,946.05 4,946.05(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Link Pharma Chem Ltd Chemicals
- Indian Private
- BSE Code : 4450.0
- ISIN : INE302F01011
-
Today’s Low
26.10 -
Today’s High
27.44
-
Open
27.44 -
Perv Close
27.44 -
52W Low
21.00 -
52W High
41.90
Key Indicators
-
P/E(TTM)
0.00
-
Mar.Cap (₹Cr.)
11.62
-
Div & Yield %
0.00
-
Book Value(₹)
28.80
-
Debt-Equity Ratio
-4.63
-
AGM Date
11-Sep-2026
-
EPS
0.00
-
P/E Ratio
0.00
Financials Ratios
-
Debt-Equity Ratio
-
-
Mar.Cap (₹Cr.)
11.62
-
RONW (%)
-
-
ROCE (%)
-
Score Board
-
Equity (₹ in Cr.)
4.44
-
BV (₹)
28.80
-
Sales( ₹ in Cr.)
27.43
-
NP (in Cr.)
0.08
-
NP Var(%)
107.0
-
Div%
0.0
-
CPS (₹)
2.40
-
EPS (₹)
0.20
-
Traded Value (₹ in Lakhs)
11.62
-
52 Week High
41.90
-
52 Week Low
21.00
-
Price BSE
26.0
-
Price NSE
0.00
-
Market Capital( in Cr.)
11.62
-
P/C Ratio
10.90
-
P/E Ratio
150.10
-
Price Vs.BV
0.20
-
20-Aug-2026( 09:27)
Corporate News - Link... - Link Pharma Chem Limited annou...
-
20-Aug-2026( 09:27)
Corporate News - Link... - Link Pharma Chem Limited annou...
-
29-Jul-2026( 09:57)
Corporate News - Link... - Link Pharma Chem will hold a m...
-
28-Jul-2026( 11:09)
Corporate News - Link... - Link Pharma Chem announced tha...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2026 Mar | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 27.43 | 25.43 | 29.90 | 38.76 | 53.56 | 34.81 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 27.43 | 25.43 | 29.90 | 38.76 | 53.56 | 34.81 |
| Other Income | 0.20 | 0.19 | 0.64 | -0.15 | 0.46 | 0.02 |
| Stock Adjustments | -0.14 | -1.33 | -2.31 | 5.04 | 1.45 | 0.16 |
| Total Income | 27.49 | 24.29 | 28.23 | 43.65 | 55.47 | 34.99 |
| EXPENDITURE : | ||||||
| Raw Materials | 10.62 | 11.22 | 14.37 | 26.41 | 37.89 | 17.93 |
| Power and Fuel Cost | 3.23 | 3.11 | 2.70 | 3.49 | 2.80 | 2.71 |
| Employee Cost | 6.09 | 5.39 | 5.52 | 5.69 | 5.77 | 5.63 |
| Other Manufacturing Expenses | 2.92 | 2.22 | 3.35 | 3.11 | 3.00 | 3.71 |
| Selling and Administration Expenses | 2.20 | 1.73 | 1.72 | 1.53 | 1.64 | 1.56 |
| Miscellaneous Expenses | 0.79 | 0.32 | 0.58 | 0.85 | 0.38 | 0.45 |
| Employee Benefit Expenses | 6.09 | 5.39 | 5.52 | 5.69 | 5.77 | 5.63 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 25.86 | 23.98 | 28.24 | 41.09 | 51.48 | 31.99 |
| Operating Profit | 1.65 | 0.32 | -0.01 | 2.57 | 4.00 | 2.99 |
| Interest | 0.53 | 0.78 | 0.87 | 0.76 | 0.45 | 0.44 |
| Gross Profit | 1.12 | -0.46 | -0.88 | 1.81 | 3.55 | 2.55 |
| Depreciation | 0.98 | 0.94 | 1.03 | 0.92 | 0.93 | 0.87 |
| Profit Before Tax | 0.14 | -1.40 | -1.91 | 0.89 | 2.62 | 1.68 |
| Current Tax | 0.00 | 0.03 | 0.01 | 0.42 | 0.67 | 0.64 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.06 | -0.40 | -0.56 | -0.18 | 0.07 | -0.05 |
| Reported Net Profit | 0.08 | -1.03 | -1.36 | 0.65 | 1.88 | 1.08 |
| Extraordinary Items | 0.00 | 0.00 | 0.08 | 0.08 | 0.44 | -0.13 |
| Adjusted Net Profit | 0.08 | -1.03 | -1.44 | 0.57 | 1.44 | 1.21 |
| Adjustment below Net Profit | 0.05 | -0.02 | 0.03 | -0.09 | 0.03 | 0.04 |
| P & L Balance brought forward | 5.34 | 6.39 | 7.72 | 7.15 | 5.24 | 4.12 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | 5.47 | 5.34 | 6.39 | 7.72 | 7.15 | 5.25 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 0.17 | -2.31 | -3.07 | 1.47 | 4.24 | 2.44 |
| Earnings Per Share(Adj)-Unit Curr | 0.17 | -2.31 | -3.07 | 1.47 | 4.24 | 2.44 |
| Book Value | 28.80 | 28.51 | 30.87 | 33.87 | 32.60 | 28.29 |
| Book Value(Adj)-Unit Curr | 28.80 | 28.51 | 30.87 | 33.87 | 32.60 | 28.29 |
